Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Trials
Published in: Trials 1/2024

Open Access 01-12-2024 | Probiotics | Study protocol

Probiotic supplementation and risk of necrotizing enterocolitis and mortality among extremely preterm infants—the Probiotics in Extreme Prematurity in Scandinavia (PEPS) trial: study protocol for a multicenter, double-blinded, placebo-controlled, and registry-based randomized controlled trial

Authors: Sofia Söderquist Kruth, Carl Willers, Emma Persad, Elisabeth Stoltz Sjöström, Susanne Rautiainen Lagerström, Alexander Rakow

Published in: Trials | Issue 1/2024

Login to get access

Abstract

Background

Extremely preterm infants, defined as those born before 28 weeks’ gestational age, are a very vulnerable patient group at high risk for adverse outcomes, such as necrotizing enterocolitis and death. Necrotizing enterocolitis is an inflammatory gastrointestinal disease with high incidence in this cohort and has severe implications on morbidity and mortality. Previous randomized controlled trials have shown reduced incidence of necrotizing enterocolitis among older preterm infants following probiotic supplementation. However, these trials were underpowered for extremely preterm infants, rendering evidence for probiotic supplementation in this population insufficient to date.

Methods

The Probiotics in Extreme Prematurity in Scandinavia (PEPS) trial is a multicenter, double-blinded, placebo-controlled and registry-based randomized controlled trial conducted among extremely preterm infants (n = 1620) born at six tertiary neonatal units in Sweden and four units in Denmark. Enrolled infants will be allocated to receive either probiotic supplementation with ProPrems® (Bifidobacterium infantis, Bifidobacterium lactis, and Streptococcus thermophilus) diluted in 3 mL breastmilk or placebo (0.5 g maltodextrin powder) diluted in 3 mL breastmilk per day until gestational week 34. The primary composite outcome is incidence of necrotizing enterocolitis and/or mortality. Secondary outcomes include incidence of late-onset sepsis, length of hospitalization, use of antibiotics, feeding tolerance, growth, and body composition at age of full-term and 3 months corrected age after hospital discharge.

Discussion

Current recommendations for probiotic supplementation in Sweden and Denmark do not include extremely preterm infants due to lack of evidence in this population. However, this young subgroup is notably the most at risk for experiencing adverse outcomes. This trial aims to investigate the effects of probiotic supplementation on necrotizing enterocolitis, death, and other relevant outcomes to provide sufficiently powered, high-quality evidence to inform probiotic supplementation guidelines in this population. The results could have implications for clinical practice both in Sweden and Denmark and worldwide.

Trial registration

(Clinicaltrials.​gov): NCT05604846
Appendix
Available only for authorised users
Literature
1.
2.
Group E. Incidence of and risk factors for neonatal morbidity after active perinatal care: extremely preterm infants study in Sweden (EXPRESS). Acta paediatrica (Oslo, Norway : 1992). 2010;99(7):978-92.
3.
4.
5.
Athalye-Jape G, Esvaran M, Patole S, Simmer K, Nathan E, Doherty D, et al. Effect of single versus multistrain probiotic in extremely preterm infants: a randomised trial. BMJ open gastroenterol. 2022;9(1)
6.
Sowden M, van Weissenbruch MM, Bulabula ANH, van Wyk L, Twisk J, van Niekerk E. Effect of a Multi-Strain Probiotic on the Incidence and Severity of Necrotizing Enterocolitis and Feeding Intolerances in Preterm Neonates. Nutrients. 2022;14(16)
7.
Cui X, Shi Y, Gao S, Xue X, Fu J. Effects of Lactobacillus reuteri DSM 17938 in preterm infants: a double-blinded randomized controlled study. Italian j pediatr. 2019;45(1):140.CrossRef
8.
Costeloe K, Hardy P, Juszczak E, Wilks M, Millar MR, Probiotics in Preterm Infants Study Collaborative G. Bifidobacterium breve BBG-001 in very preterm infants: a randomised controlled phase 3 trial. Lancet (London, England). 2016;387(10019):649-60.
9.
Hays S, Jacquot A, Gauthier H, Kempf C, Beissel A, Pidoux O, et al. Probiotics and growth in preterm infants: A randomized controlled trial PREMAPRO study. Clin Nutr. 2016;35(4):802–11.PubMedCrossRef
10.
Dilli D, Aydin B, Fettah ND, Özyazıcı E, Beken S, Zenciroğlu A, et al. The propre-save study: effects of probiotics and prebiotics alone or combined on necrotizing enterocolitis in very low birth weight infants. J Pediatr. 2015;166(3):545–51.e1.PubMedCrossRef
11.
Demirel G, Erdeve O, Celik IH, Dilmen U. Saccharomyces boulardii for prevention of necrotizing enterocolitis in preterm infants: a randomized, controlled study. Acta paediatrica (Oslo, Norway : 1992). 2013;102(12):e560-5.
12.
Jacobs SE, Tobin JM, Opie GF, Donath S, Tabrizi SN, Pirotta M, et al. Probiotic effects on late-onset sepsis in very preterm infants: a randomized controlled trial. Pediatrics. 2013;132(6):1055–62.PubMedCrossRef
13.
Lin HC, Hsu CH, Chen HL, Chung MY, Hsu JF, Lien RI, et al. Oral probiotics prevent necrotizing enterocolitis in very low birth weight preterm infants: a multicenter, randomized, controlled trial. Pediatrics. 2008;122(4):693–700.PubMedCrossRef
14.
Chi C, Li C, Buys N, Wang W, Yin C, Sun J. Effects of Probiotics in Preterm Infants: A Network Meta-analysis. Pediatrics. 2021;147(1)
15.
van den Akker CHP, van Goudoever JB, Shamir R, Domellöf M, Embleton ND, Hojsak I, et al. Probiotics and Preterm Infants: A Position Paper by the European Society for Paediatric Gastroenterology Hepatology and Nutrition Committee on Nutrition and the European Society for Paediatric Gastroenterology Hepatology and Nutrition Working Group for Probiotics and Prebiotics. J pediatr gastroenterol nutrit. 2020;70(5):664–80.CrossRef
16.
17.
Xiong T, Maheshwari A, Neu J, Ei-Saie A, Pammi M. An Overview of Systematic Reviews of Randomized-Controlled Trials for Preventing Necrotizing Enterocolitis in Preterm Infants. Neonatology. 2020;117(1):46–56.PubMedCrossRef
18.
McFarland LV, Evans CT, Goldstein EJC. Strain-Specificity and Disease-Specificity of Probiotic Efficacy: A Systematic Review and Meta-Analysis. Front Med (Lausanne). 2018;5:124.PubMedPubMedCentralCrossRef
19.
van den Akker CHP, van Goudoever JB, Szajewska H, Embleton ND, Hojsak I, Reid D, et al. Probiotics for Preterm Infants: A Strain-Specific Systematic Review and Network Meta-analysis. J pediatr gastroenterol nutrit. 2018;67(1):103–22.CrossRef
20.
Dermyshi E, Wang Y, Yan C, Hong W, Qiu G, Gong X, et al. The "Golden Age" of Probiotics: A Systematic Review and Meta-Analysis of Randomized and Observational Studies in Preterm Infants. Neonatol. 2017;112(1):9–23.CrossRef
21.
Aceti A, Maggio L, Beghetti I, Gori D, Barone G, Callegari ML, et al. Probiotics Prevent Late-Onset Sepsis in Human Milk-Fed, Very Low Birth Weight Preterm Infants: Systematic Review and Meta-Analysis. Nutrients. 2017;9(8)
22.
Hu HJ, Zhang GQ, Zhang Q, Shakya S, Li ZY. Probiotics Prevent Candida Colonization and Invasive Fungal Sepsis in Preterm Neonates: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Pediatr Neonatol. 2017;58(2):103–10.PubMedCrossRef
23.
Rees CM, Hall NJ, Fleming P, Eaton S. Probiotics for the prevention of surgical necrotising enterocolitis: systematic review and meta-analysis. BMJ paediatrics open. 2017;1(1):e000066.PubMedPubMedCentralCrossRef
24.
Sun J, Marwah G, Westgarth M, Buys N, Ellwood D, Gray PH. Effects of Probiotics on Necrotizing Enterocolitis, Sepsis, Intraventricular Hemorrhage, Mortality, Length of Hospital Stay, and Weight Gain in Very Preterm Infants: A Meta-Analysis. Adv Nutr. 2017;8(5):749–63.PubMedPubMedCentralCrossRef
25.
Thomas JP, Raine T, Reddy S, Belteki G. Probiotics for the prevention of necrotising enterocolitis in very low-birth-weight infants: a meta-analysis and systematic review. Acta paediatrica (Oslo, Norway : 1992). 2017;106(11):1729-41.
26.
Baucells BJ, Mercadal Hally M, Álvarez Sánchez AT, Figueras AJ. Probiotic associations in the prevention of necrotising enterocolitis and the reduction of late-onset sepsis and neonatal mortality in preterm infants under 1,500g: A systematic review. An Pediatr (Barc). 2016;85(5):247–55.PubMedCrossRef
27.
Sawh SC, Deshpande S, Jansen S, Reynaert CJ, Jones PM. Prevention of necrotizing enterocolitis with probiotics: a systematic review and meta-analysis. PeerJ. 2016;4:e2429.PubMedPubMedCentralCrossRef
28.
Kothari D, Patel S, Kim SK. Probiotic supplements might not be universally-effective and safe: A review. Biomed pharmacotherapy Biomed pharmacotherapie. 2019;111:537–47.CrossRef
29.
Isani MA, Delaplain PT, Grishin A, Ford HR. Evolving understanding of neonatal necrotizing enterocolitis. Curr Opin Pediatr. 2018;30(3):417–23.PubMedCrossRef
30.
Glaser AM, Hughes. Neonatal Sepsis A review of pathophysiology and current management strategies. Advances in Neonatal Care. 2021;21(1):49–60.PubMedCrossRef
31.
Dong Y, Speer CP. Late-onset neonatal sepsis: recent developments. Arch Dis Child Fetal Neonatal Ed. 2015;100(3):F257–63.PubMedCrossRef
32.
Greenwood C, Morrow AL, Lagomarcino AJ, Altaye M, Taft DH, Yu Z, et al. Early empiric antibiotic use in preterm infants is associated with lower bacterial diversity and higher relative abundance of Enterobacter. J Pediatr. 2014;165(1):23–9.PubMedPubMedCentralCrossRef
33.
Ganapathy V, Hay JW, Kim JH, Lee ML, Rechtman DJ. Long term healthcare costs of infants who survived neonatal necrotizing enterocolitis: a retrospective longitudinal study among infants enrolled in Texas Medicaid. BMC pediatrics. 2013;13:127.PubMedPubMedCentralCrossRef
34.
Federici S, De Biagi L. Long Term Outcome of Infants with NEC. Curr Pediatr Rev. 2019;15(2):111–4.PubMedCrossRef
35.
Berrington JE, Zalewski S. The future of probiotics in the preterm infant. Early Hum Dev. 2019;135:75–81.PubMedCrossRef
36.
Moschino L, Verlato G, Duci M, Cavicchiolo ME, Guiducci S, Stocchero M, et al. The Metabolome and the Gut Microbiota for the Prediction of Necrotizing Enterocolitis and Spontaneous Intestinal Perforation: A Systematic Review. Nutrients. 2022;14(18)
37.
Uzan-Yulzari A, Turta O, Belogolovski A, Ziv O, Kunz C, Perschbacher S, et al. Neonatal antibiotic exposure impairs child growth during the first six years of life by perturbing intestinal microbial colonization. Nat Commun. 2021;12(1):443.PubMedPubMedCentralCrossRef
38.
Westerbeek EA, van den Berg A, Lafeber HN, Knol J, Fetter WP, van Elburg RM. The intestinal bacterial colonisation in preterm infants: a review of the literature. Clin Nutr. 2006;25(3):361–8.PubMedCrossRef
39.
Bermudez-Brito M, Plaza-Díaz J, Muñoz-Quezada S, Gómez-Llorente C, Gil A. Probiotic mechanisms of action. Ann nutrit metabol. 2012;61(2):160–74.CrossRef
40.
Hidalgo-Cantabrana C, Delgado S, Ruiz L, Ruas-Madiedo P, Sánchez B, Margolles A. Bifidobacteria and Their Health-Promoting Effects. Microbiol Spectr. 2017;5(3)
41.
Pell LG, Loutet MG, Roth DE, Sherman PM. Arguments against routine administration of probiotics for NEC prevention. Curr Opin Pediatr. 2019;31(2):195–201.PubMedCrossRef
42.
Suez J, Zmora N, Segal E, Elinav E. The pros, cons, and many unknowns of probiotics. Nat Med. 2019;25(5):716–29.PubMedCrossRef
43.
Sharif S, Meader N, Oddie SJ, Rojas-Reyes MX, McGuire W. Probiotics to prevent necrotising enterocolitis in very preterm or very low birth weight infants. Cochrane Database Syst Rev. 2023;7(7):Cd005496.PubMed
44.
Al-Hosni M, Duenas M, Hawk M, Stewart LA, Borghese RA, Cahoon M, et al. Probiotics-supplemented feeding in extremely low-birth-weight infants. J Perinatol. 2012;32(4):253–9.PubMedCrossRef
45.
Singh B, Shah PS, Afifi J, Simpson CD, Mitra S, Dow K, et al. Probiotics for preterm infants: A National Retrospective Cohort Study. J Perinatol. 2019;39(4):533–9.PubMedCrossRef
46.
Adams M, Bassler D, Darlow BA, Lui K, Reichman B, Hakansson S, et al. Preventive strategies and factors associated with surgically treated necrotising enterocolitis in extremely preterm infants: an international unit survey linked with retrospective cohort data analysis. BMJ Open. 2019;9(10):e031086.PubMedPubMedCentralCrossRef
47.
Bonnar K, Fraser D. Extrauterine Growth Restriction in Low Birth Weight Infants. Neonatal network : NN. 2019;38(1):27–33.PubMedCrossRef
48.
Moltu SJ, Bronsky J, Embleton N, Gerasimidis K, Indrio F, Köglmeier J, et al. Nutritional Management of the Critically Ill Neonate: A Position Paper of the ESPGHAN Committee on Nutrition. J pediat gastroenterol nutrit. 2021;73(2):274–89.CrossRef
49.
Stoltz Sjöström E, Öhlund I, Ahlsson F, Engström E, Fellman V, Hellström A, et al. Nutrient intakes independently affect growth in extremely preterm infants: results from a population-based study. Acta paediatrica (Oslo, Norway : 1992). 2013;102(11):1067-74.
50.
Latal-Hajnal B, von Siebenthal K, Kovari H, Bucher HU, Largo RH. Postnatal growth in VLBW infants: significant association with neurodevelopmental outcome. J Pediatr. 2003;143(2):163–70.PubMedCrossRef
51.
Ottolini KM, Andescavage N, Keller S, Limperopoulos C. Nutrition and the developing brain: the road to optimizing early neurodevelopment: a systematic review. Pediatric res. 2020;87(2):194–201.CrossRef
52.
Kawasaki Y, Yoshida T, Matsui M, Hiraiwa A, Inomata S, Tamura K, et al. Clinical Factors That Affect the Relationship between Head Circumference and Brain Volume in Very-Low-Birth-Weight Infants. J Neuroimaging. 2019;29(1):104–10.PubMedCrossRef
53.
Giannì ML, Roggero P, Colnaghi MR, Piemontese P, Amato O, Orsi A, et al. The role of nutrition in promoting growth in pre-term infants with bronchopulmonary dysplasia: a prospective non-randomised interventional cohort study. BMC pediatrics. 2014;14:235.PubMedPubMedCentralCrossRef
54.
Arigliani M, Spinelli AM, Liguoro I, Cogo P. Nutrition and Lung Growth. Nutrients. 2018;10:7.CrossRef
55.
Koletzko B, Brands B, Grote V, Kirchberg FF, Prell C, Rzehak P, et al. Long-Term Health Impact of Early Nutrition: The Power of Programming. Ann nutrit metabol. 2017;70(3):161–9.CrossRef
56.
Kerkhof GF, Willemsen RH, Leunissen RW, Breukhoven PE, Hokken-Koelega AC. Health profile of young adults born preterm: negative effects of rapid weight gain in early life. J clin endocrinol metabol. 2012;97(12):4498–506.CrossRef
57.
Pfister KM, Zhang L, Miller NC, Ingolfsland EC, Demerath EW, Ramel SE. Early body composition changes are associated with neurodevelopmental and metabolic outcomes at 4 years of age in very preterm infants. Pediatric res. 2018;84(5):713–8.CrossRef
58.
Ramel SE, Haapala J, Super J, Boys C, Demerath EW. Nutrition, Illness and Body Composition in Very Low Birth Weight Preterm Infants: Implications for Nutritional Management and Neurocognitive Outcomes. Nutrients. 2020;12(1).
59.
Hamatschek C, Yousuf EI, Möllers LS, So HY, Morrison KM, Fusch C, et al. Fat and Fat-Free Mass of Preterm and Term Infants from Birth to Six Months: A Review of Current Evidence. Nutrients. 2020;12(2)
60.
61.
Oddie SJ, Young L, McGuire W. Slow advancement of enteral feed volumes to prevent necrotising enterocolitis in very low birth weight infants. Cochrane Database Syst Rev. 2021;8:CD001241.PubMed
62.
Viswanathan S, McNelis K, Super D, Einstadter D, Groh-Wargo S, Collin M. Standardized Slow Enteral Feeding Protocol and the Incidence of Necrotizing Enterocolitis in Extremely Low Birth Weight Infants. JPEN J parent enter nutrit. 2015;39(6):644–54.CrossRef
63.
de Waard M, Li Y, Zhu Y, Ayede AI, Berrington J, Bloomfield FH, et al. Time to Full Enteral Feeding for Very Low-Birth-Weight Infants Varies Markedly Among Hospitals Worldwide But May Not Be Associated With Incidence of Necrotizing Enterocolitis: The NEOMUNE-NeoNutriNet Cohort Study. JPEN J parent enter nutrit. 2019;43(5):658–67.CrossRef
64.
Lucchini R, Bizzarri B, Giampietro S, De Curtis M. Feeding intolerance in preterm infants. How to understand the warning signs. J Matern Fetal Neonatal Med. 2011;24(Suppl 1):72–4.PubMedCrossRef
65.
Aceti A, Gori D, Barone G, Callegari ML, Fantini MP, Indrio F, et al. Probiotics and Time to Achieve Full Enteral Feeding in Human Milk-Fed and Formula-Fed Preterm Infants: Systematic Review and Meta-Analysis. Nutrients. 2016;8(8)
66.
Zhang W, Wang S, Xing Y, Wang H, Fu B, Long M, et al. Clinical efficacy of probiotics on feeding intolerance in preterm infants: a systematic review and meta-analysis. Transl Pediatr. 2022;11(2):229–38.PubMedPubMedCentralCrossRef
67.
Mitha A, Kruth SS, Bjurman S, Rakow A, Johansson S. Neonatal Morbidities and Feeding Tolerance Outcomes in Very Preterm Infants, before and after Introduction of Probiotic Supplementation. Nutrients. 2022;14(17)
68.
Chan AW, Tetzlaff JM, Altman DG, Laupacis A, Gøtzsche PC, Krleža-Jerić K, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann inter med. 2013;158(3):200–7.CrossRef
69.
Hopewell S, Boutron I, Chan AW, Collins GS, de Beyer JA, Hróbjartsson A, et al. An update to SPIRIT and CONSORT reporting guidelines to enhance transparency in randomized trials. Nat Med. 2022;28(9):1740–3.PubMedCrossRef
70.
Schimmoeller ME, Wulf KL, Walker C, Barrett-Reis B, Vurma M. Use of probiotics in the NICU: Evaluating the stability of a three-strain probiotic blend in various media for enteral feeding. J neonat-perinat med. 2022;15(2):351–6.CrossRef
71.
Bell MJ, Ternberg JL, Feigin RD, Keating JP, Marshall R, Barton L, et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann surg. 1978;187(1):1–7.PubMedPubMedCentralCrossRef
72.
Forsum E, Olhager E, Törnqvist C. An Evaluation of the Pea Pod System for Assessing Body Composition of Moderately Premature Infants. Nutrients. 2016;8(4):238.PubMedPubMedCentralCrossRef
73.
74.
Metadata
Title
Probiotic supplementation and risk of necrotizing enterocolitis and mortality among extremely preterm infants—the Probiotics in Extreme Prematurity in Scandinavia (PEPS) trial: study protocol for a multicenter, double-blinded, placebo-controlled, and registry-based randomized controlled trial
Authors
Sofia Söderquist Kruth
Carl Willers
Emma Persad
Elisabeth Stoltz Sjöström
Susanne Rautiainen Lagerström
Alexander Rakow
Publication date
01-12-2024
Publisher
BioMed Central
Keyword
Probiotics
Published in
Trials / Issue 1/2024
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-024-08088-8

Other articles of this Issue 1/2024

Trials 1/2024 Go to the issue

Study protocol

Determining the effects of targeted high-definition transcranial direct current stimulation on reducing post-stroke upper limb motor impairments—a randomized cross-over study

Study protocol

A physiotherapy group exercise and self-management approach to improve physical activity in people with mild-moderate Parkinson’s disease: a randomized controlled trial

Study protocol

Implementation of supplemental physiotherapy following hip fracture surgery: a protocol for the process evaluation of a randomised controlled trial

Study protocol

Optimization of cardiopulmonary bypass prime fluid to preserve microcirculatory perfusion during on-pump coronary artery bypass graft surgery: PRIME study protocol for a double-blind randomized trial

Study protocol

Does somatosensory discrimination therapy alter sensorimotor upper limb function differently compared to motor therapy in children and adolescents with unilateral cerebral palsy: study protocol for a randomized controlled trial

Study protocol

Effectiveness of WeChat-assisted preoperative education to reduce perioperative anxiety in breast cancer patients: a prospective randomized controlled study protocol